advertisement
November 18, 2009—At the 36th Annual VEITH Symposium in New York City, Ekos Corporation (Bothell, WA) launched the EkoSonic MACH4e with rapid pulse modulation for the dissolution of vascular blood clots.
According to the company, the device can be used throughout the peripheral vasculature, including veins, arteries, inferior vena cava filters, and difficult-to-reach places (such as behind valves), and exposes clots to a greater drug uptake. The MACH4e uses 50% to 70% less lytic drug and shows no thrombus fracture, reducing the risk of distal embolism, with no hemolysis or damage to valves or vascular wall. The device demonstrated a high level of vessel patency. The MACH4e removes the thrombus more completely, possibly reducing the risk of postthrombotic syndrome, Ekos stated.
Click here for more industry news and clinical trial updates.
TOP 5 ARTICLES FROM 2009
- SFA Disease: The Lay of the Land
How anatomical challenges affect device choices for revascularization.
by Subhash Banerjee, MD, and Tony S. Das, MD
- Renal Artery Stenosis and the Interventionist
Despite improved treatment options, the need for consensus among specialties remains.
by James A. M. Smith, DO
- Flow Diversion for Intracranial Aneurysm Treatment
How this new technology may expand the types of intracranial aneurysms that can be treated.
by David Fiorella, MD, PhD; Michael Kelly, MD; and Henry Woo, MD
- Inferior Vena Cava Filter Retrieval
Tips on the best methods for retrieving an IVC filter.
by Thuong G. Van Ha, MD
- Snorkel Procedures for TEVAR
Two case studies demonstrate how this procedure ensures left carotid artery patency during thoracic endovascular aortic repair.
by Grace J. Wang, MD, and Edward Y. Woo, MD
Sides Media